26Aug 2023
LEAP2 is associated with cardiometabolic markers but is unchanged by antidiabetic treatment in people with prediabetes

LEAP2 is associated with cardiometabolic markers but is unchanged by antidiabetic treatment in people with prediabetes

Delve into the emerging significance of LEAP2 in metabolic health. Secreted by the liver, LEAP2 levels rise with obesity, insulin resistance, and liver enzyme elevation. Independently predicted by fasting glucose, body mass, and liver enzymes, LEAP2 is inversely linked to impaired kidney function, suggesting potential implications for metabolic risk and weight control.

  • #endo-diabetology

Like

Save

Share